相关实验视频

Updated: Feb 21, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

在死角性肠球炎中NLRP3炎症酶的作用

Xiuhui Chen^1,2, Rui Long^1,3, Fengdan Xu^1,3

¹Dongguan Children's Hospital Affiliated to Guangdong Medical University, The Eighth People's Hospital of Dongguan, Dongguan, 523000, China.

Pediatric research

|June 5, 2025

概括

类似NOD的受体pyrin域含有蛋白3 (NLRP3) 炎症体与新生儿死性肠球炎 (NEC) 病原发生有关. 抑制NLRP3炎症酶激活为NEC提供了一个有前途的治疗策略.

科学领域:

新生儿免疫学新生儿免疫学
胃肠病学胃肠病学
炎症研究的研究.

背景情况:

死性肠球炎 (NEC) 是一种严重的胃肠道疾病,影响新生儿.
类似NOD的受体pyrin域含蛋白3 (NLRP3) 炎症体在炎症反应中起着至关重要的作用.
在NEC病变发生过程中,NLRP3炎症酶的过度活化越来越多地被发现.

研究的目的:

审查NLRP3炎症酶激活与新生儿NEC之间的关联.
讨论NLRP3炎症酶过活化在NEC发育中的作用.
探索针对NEC的NLRP3炎症酶抑制的治疗策略.

主要方法:

对研究NLRP3炎症酶和NEC的文献综述.
对NLRP3炎症酶活性的分子和蛋白调节剂的分析.
检查NLRP3炎症酶抑制剂的药理机制.

主要成果:

在临床NEC病例和实验模型中,证据支持NLRP3炎症酶过度激活.
特定的分子和蛋白质被确定为NEC中NLRP3炎症酶的关键调节者.
详细介绍了抑制NLRP3炎症酶激活的各种策略.

结论:

NLRP3炎症酶是NEC的重要贡献者.
准NLRP3炎症酶激活为NEC提供了潜在的治疗益处.
新型NLRP3炎症酶抑制剂的开发是未来NEC疗法的关键重点.

更多相关视频

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

相关概念视频

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...